Delivery Order SPE2DB22D2009-SPE2DB25FL9GL

Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,156.97 contract is for the supply of the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, with a period of performance through February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This is a $1,130.17 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a completion date of May 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $6,140.06 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and medical...
This is a $11,706.24 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, which is used for medical treatment. The delivery order has a period of performance through March 19, 2025 and was awarded on March 18, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a $4,263.38 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a period of performance through December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $1,645.62 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML and has a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,672.94, is for the supply of the prescription medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which enables the company to provide a wide range of pharmaceutical products and medical...
This is a $3,698.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a $12,270.42 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the prescription medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a period of performance through August 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $2,360.40 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, and has an ultimate completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL9GL
    Delivery Order

This is a $1,908.87 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of the medication WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a performance period through May 19, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to provide a wide range of pharmaceutical products and medical supplies to support military and government healthcare programs worldwide. This delivery order is not designated as a set-aside contract, indicating open competition.

Generated 8/15/25, 10:00 AM